Anvisa sedia fórum internacional sobre biofármaco
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5375523
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5375523
Appel a candidature interne – Administrateur Direction d’Epidémiologie, des Laboratoires et de la Recherche (DELR)
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5375310
Pro Doc Limitée voluntarily recalls two lots of irbesartan drugs because of nitrosamine impurity
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69328a-eng.php
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5372775
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5372451
Note de Presse (Hôpital Universitaire la Paix)
TECENTRIQ (atezolizumab) – Risk of Immune-Related Myositis
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69274a-eng.php